As fat mass decreases due to weight loss, the secretion of adipokines changes, which can impact hormone levels involved in the menstrual cycle, such as estrogen and progesterone
Key Takeaways GLP-1 medications are associated with a higher risk of gallstones and gallbladder disease, and FDA labeling for Zepbound and Wegovy lists gallstones and acute cholecystitis as possible risks
Article PubMed Google Scholar Conte, C., Hall, K
Other research, though, suggests that GLP-1 drugs may reduce cravings and use of alcohol.
Its been heartwarming to see our patients gain confidence and better healthboth in person and virtually
GLP-1 (glucagon-like peptide-1) helps regulate blood sugar, reduce appetite, and increase feelings of fullness, making it easier for patients to manage their weight